Cargando…
Immune Checkpoints in Cancers: From Signaling to the Clinic
SIMPLE SUMMARY: Immune checkpoint therapies are treatments used to fight cancers by reactivating a patient’s own immune system. Melanoma was the first cancer to benefit from these treatments. Despite a clear benefit for patients and the existence of long responders, most patients fail to respond or...
Autores principales: | Pisibon, Céline, Ouertani, Amira, Bertolotto, Corine, Ballotti, Robert, Cheli, Yann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468441/ https://www.ncbi.nlm.nih.gov/pubmed/34572799 http://dx.doi.org/10.3390/cancers13184573 |
Ejemplares similares
-
The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
por: Ballotti, Robert, et al.
Publicado: (2020) -
An Update on the Role of Ubiquitination in Melanoma Development and Therapies
por: Soysouvanh, Frédéric, et al.
Publicado: (2021) -
The “ART” of Epigenetics in Melanoma: From histone “Alterations, to Resistance and Therapies”
por: Strub, Thomas, et al.
Publicado: (2020) -
CD271 is an imperfect marker for melanoma initiating cells
por: Cheli, Yann, et al.
Publicado: (2014) -
Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
por: Krossa, Imène, et al.
Publicado: (2022)